These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34708273)

  • 1. ASO Author Reflections: Constructing a Transgender and Nonbinary Cohort to Analyze Breast Cancer Screening.
    Ascha M; Felt D; Beach LB; Kulkarni SA; Jordan SW
    Ann Surg Oncol; 2022 Mar; 29(3):1718-1719. PubMed ID: 34708273
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast Cancer Risk and Screening in Transgender Persons: A Call for Inclusive Care.
    Clarke CN; Cortina CS; Fayanju OM; Dossett LA; Johnston FM; Wong SL
    Ann Surg Oncol; 2022 Apr; 29(4):2176-2180. PubMed ID: 34097159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Cancer Screening in Transgender Women.
    Vasilev DV; Kling JM; Carroll EF
    J Womens Health (Larchmt); 2023 Sep; 32(9):905-907. PubMed ID: 36735540
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast Cancer Risk Assessment and Screening in Transgender Patients.
    Pivo S; Montes J; Schwartz S; Chun J; Kiely D; Hazen A; Schnabel F
    Clin Breast Cancer; 2017 Aug; 17(5):e225-e227. PubMed ID: 28428098
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Will Breast Cancer Screening Become Personalized?
    Allweis TM; Hermann N
    Ann Surg Oncol; 2021 Aug; 28(8):4318-4319. PubMed ID: 33393021
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Breast Cancer Screening in the Safety-Net: Trying to Close the Gap When the Fault Lines Go Deep.
    Ahmadiyeh N
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):684-685. PubMed ID: 32712890
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data.
    Kiran T; Davie S; Singh D; Hranilovic S; Pinto AD; Abramovich A; Lofters A
    Can Fam Physician; 2019 Jan; 65(1):e30-e37. PubMed ID: 30674526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-reported Rates of Abuse, Neglect, and Bullying Experienced by Transgender and Gender-Nonbinary Adolescents in China.
    Peng K; Zhu X; Gillespie A; Wang Y; Gao Y; Xin Y; Qi J; Ou J; Zhong S; Zhao L; Liu J; Wang C; Chen R
    JAMA Netw Open; 2019 Sep; 2(9):e1911058. PubMed ID: 31490542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASO Author Reflections: Optimizing Breast Cancer Risk Assessment and Screening Among Black Women.
    Crown A; Joseph KA
    Ann Surg Oncol; 2023 Mar; 30(3):1722-1723. PubMed ID: 36138285
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Disparities in Breast Cancer Screening Rates Among Adults With and Without Intellectual and Developmental Disabilities.
    Khan MMM; Munir MM; Pawlik TM
    Ann Surg Oncol; 2024 Feb; 31(2):997-998. PubMed ID: 37906381
    [No Abstract]   [Full Text] [Related]  

  • 11. Culturally safe, high-quality breast cancer screening for transgender people: A scoping review protocol.
    Peters MDJ; Ramsey I; Kennedy K; Sharplin G; Eckert M
    J Adv Nurs; 2022 Jan; 78(1):276-281. PubMed ID: 34816475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASO Author Reflections: Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates among U.S. Counties.
    Herbert C; Paro A; Diaz A; Pawlik TM
    Ann Surg Oncol; 2022 Feb; 29(2):849-850. PubMed ID: 34599435
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast cancer screening in transgender patients: findings from the 2014 BRFSS survey.
    Narayan A; Lebron-Zapata L; Morris E
    Breast Cancer Res Treat; 2017 Dec; 166(3):875-879. PubMed ID: 28828563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gynecologic cancer screening in the transgender male population and its current challenges.
    Patel JM; Dolitsky S; Bachman GA; Buckley de Meritens A
    Maturitas; 2019 Nov; 129():40-44. PubMed ID: 31547911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to Mammography Screening Guidelines Among Transgender Persons and Sexual Minority Women.
    Bazzi AR; Whorms DS; King DS; Potter J
    Am J Public Health; 2015 Nov; 105(11):2356-8. PubMed ID: 26378843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autistic traits in individuals self-defining as transgender or nonbinary.
    Stagg SD; Vincent J
    Eur Psychiatry; 2019 Sep; 61():17-22. PubMed ID: 31260907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer in transgender patients: A systematic review. Part 2: Female to Male.
    Stone JP; Hartley RL; Temple-Oberle C
    Eur J Surg Oncol; 2018 Oct; 44(10):1463-1468. PubMed ID: 30037639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and minority-stress correlates of past 12-month prescription drug misuse in a national sample of transgender and gender nonbinary adults: Results from the U.S. Transgender Survey.
    Kidd JD; Goetz TG; Shea EA; Bockting WO
    Drug Alcohol Depend; 2021 Feb; 219():108474. PubMed ID: 33360852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Cancer Screening: Transgender Discrimination and Marginalization From Pakistan Perspective.
    Khan F; Sarmad SF; Abbas F; Hafeez N; Wasim E; Kumari U; Jabbar AA
    Acad Radiol; 2023 Apr; 30(4):779. PubMed ID: 35750608
    [No Abstract]   [Full Text] [Related]  

  • 20. Abortion experiences and preferences of transgender, nonbinary, and gender-expansive people in the United States.
    Moseson H; Fix L; Ragosta S; Forsberg H; Hastings J; Stoeffler A; Lunn MR; Flentje A; Capriotti MR; Lubensky ME; Obedin-Maliver J
    Am J Obstet Gynecol; 2021 Apr; 224(4):376.e1-376.e11. PubMed ID: 32986990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.